======= C1orf51 =======
== Gene Information ==
* **Official Symbol**: CIART
* **Official Name**: circadian associated repressor of transcription
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=148523|148523]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8N365|Q8N365]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=C1orf51&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C1orf51|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/615782|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Transcriptional repressor which forms a negative regulatory component of the circadian clock and acts independently of the circadian transcriptional repressors: CRY1, CRY2 and BHLHE41. In a histone deacetylase-dependent manner represses the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Abrogates the interaction of ARNTL/BMAL1 with the transcriptional coactivator CREBBP and can repress the histone acetyl-transferase activity of the CLOCK-ARNTL/BMAL1 heterodimer, reducing histone acetylation of its target genes. Rhythmically binds the E-box elements (5'-CACGTG-3') on circadian gene promoters and its occupancy shows circadian oscillation antiphasic to ARNTL/BMAL1. Interacts with the glucocorticoid receptor (NR3C1) and contributes to the repressive function in the glucocorticoid response (By similarity). {ECO:0000250}.
No Pfam Domain information is available for this gene.
|locomotor rhythm|
|circadian behavior|
|rhythmic behavior|
|E-box binding|
|circadian regulation of gene expression|
|RNA polymerase II distal enhancer sequence-specific DNA binding|
|PML body|
|circadian rhythm|
|locomotory behavior|
|rhythmic process|
|behavior|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp539|42°C R08 exp539]]|-1.75|
|[[:results:exp170|Metformin 100 to 150μM on day4 R04 exp170]]|1.71|
|[[:results:exp187|proTAME 5μM R04 exp187]]|1.79|
|[[:results:exp496|Lead acetate 990μM R08 exp496]]|2.36|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 6856
* **Expression level (log2 read counts)**: 2.02
{{:chemogenomics:nalm6 dist.png?nolink |}}